Security
Tactile Systems Technology, Inc. Common Stock · TCMD
TCMDNASDAQCommon stockCurrentCIK 1027838Updated Nov 3, 2026
TCMD price & chart
Loading TradingView…
NASDAQ:TCMD on TradingView ↗About the company
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic respiratory conditions by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
In the news
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026 ↗
Recent filings
10-Q/A filing
10-Q/A filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 259,177,000Source | 287,724,000Source | 279,668,000Source | 273,048,000Source | 278,784,000Source | 272,116,000Source | 280,242,000Source | 272,040,000Source | 273,942,000Source | 297,924,000Source | 281,438,000Source | 254,996,000Source |
| Property, Plant and Equipment, NetUSD | 5,460,000Source | 5,878,000Source | 5,849,000Source | 4,897,000Source | 5,691,000Source | 5,196,000Source | 5,391,000Source | 6,217,000Source | 5,117,000Source | 5,603,000Source | 6,195,000Source | 6,077,000Source |
| GoodwillUSD | 31,063,000Source | 31,063,000Source | 39,554,000Source | 31,063,000Source | 31,063,000Source | 39,554,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 40,023,000Source | 43,708,000Source | 44,747,000Source | 40,904,000Source | 44,883,000Source | 42,306,000Source | 41,866,000Source | 45,795,000Source | 39,167,000Source | 42,789,000Source | 46,724,000Source | 50,375,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 65,965,000Source | 82,146,000Source | 69,853,000Source | 81,528,000Source | 73,618,000Source | 74,993,000Source | 83,619,000Source | 60,706,000Source | 83,446,000Source | 94,367,000Source | 61,033,000Source | 21,929,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 37,257,000Source | 39,970,000Source | 43,140,000Source | 33,086,000Source | 41,935,000Source | 38,219,000Source | 35,693,000Source | 40,491,000Source | 43,876,000Source | 44,937,000Source | 43,173,000Source | 54,826,000Source |
| Inventory, NetUSD | 16,084,000Source | 21,176,000Source | 16,845,000Source | 17,111,000Source | 18,846,000Source | 16,581,000Source | 18,867,000Source | 20,844,000Source | 14,025,000Source | 18,666,000Source | 22,527,000Source | 23,124,000Source |
| Assets, CurrentUSD | 141,399,000Source | 162,372,000Source | 157,602,000Source | 152,987,000Source | 151,859,000Source | 152,842,000Source | 160,122,000Source | 141,273,000Source | 165,167,000Source | 177,563,000Source | 145,294,000Source | 119,763,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 7,250,000Source | 5,127,000Source | 11,925,000Source | 6,348,000Source | 3,909,000Source | 7,851,000Source | 5,900,000Source | 4,908,000Source | 8,066,000Source | 5,053,000Source | 4,366,000Source | 3,754,000Source |
| Operating Lease, Right-of-Use AssetUSD | 14,751,000Source | 17,553,000Source | 12,553,000Source | 15,462,000Source | 17,828,000Source | 13,310,000Source | 16,174,000Source | 18,480,000Source | 13,798,000Source | 16,633,000Source | 19,128,000Source | 21,322,000Source |
| Other Assets, NoncurrentUSD | 9,736,000Source | 3,803,000Source | 10,660,000Source | 9,402,000Source | 3,541,000Source | 10,187,000Source | 7,567,000Source | 2,965,000Source | 9,847,000Source | 5,962,000Source | 2,720,000Source | 3,335,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 54,228,000Source | 79,823,000Source | 55,832,000Source | 78,122,000Source | 78,108,000Source | 54,250,000Source | 74,611,000Source | 78,567,000Source | 55,040,000Source | 81,327,000Source | 87,796,000Source | 133,596,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 22,000Source | 24,000Source | 23,000Source | 22,000Source | 24,000Source | 22,000Source | 24,000Source | 24,000Source | 22,000Source | 24,000Source | 24,000Source | 20,000Source |
| Additional Paid in CapitalUSD | 160,621,000Source | 181,739,000Source | 162,851,000Source | 158,807,000Source | 179,669,000Source | 164,667,000Source | 172,727,000Source | 176,764,000Source | 163,940,000Source | 180,719,000Source | 174,724,000Source | 131,001,000Source |
| Retained Earnings (Accumulated Deficit)USD | 44,306,000Source | 26,138,000Source | 60,962,000Source | 36,097,000Source | 20,983,000Source | 53,177,000Source | 32,880,000Source | 16,685,000Source | 54,940,000Source | 35,854,000Source | 18,894,000Source | -9,621,000Source |
| Stockholders' Equity Attributable to ParentUSD | 204,949,000Source | 207,901,000Source | 223,836,000Source | 194,926,000Source | 200,676,000Source | 217,866,000Source | 205,631,000Source | 193,473,000Source | 218,902,000Source | 216,597,000Source | 193,642,000Source | 121,400,000Source |
| Liabilities and EquityUSD | 259,177,000Source | 287,724,000Source | 279,668,000Source | 273,048,000Source | 278,784,000Source | 272,116,000Source | 280,242,000Source | 272,040,000Source | 273,942,000Source | 297,924,000Source | 281,438,000Source | 254,996,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 39,186,000Source | 37,154,000Source | 38,253,000Source | 40,403,000Source | 34,212,000Source | 36,012,000Source | 35,401,000Source | 33,133,000Source | 40,957,000Source | 40,704,000Source | 41,057,000Source | 64,330,000Source |
| Operating Lease, Liability, CurrentUSD | 3,144,000Source | 2,883,000Source | 3,095,000Source | 3,095,000Source | 2,799,000Source | 3,237,000Source | 3,036,000Source | 2,740,000Source | 3,195,000Source | 2,980,000Source | 2,807,000Source | 2,500,000Source |
| Accounts Payable, CurrentUSD | 7,989,000Source | 7,290,000Source | 7,923,000Source | 8,025,000Source | 5,094,000Source | 7,124,000Source | 7,224,000Source | 5,488,000Source | 4,968,000Source | 5,648,000Source | 6,659,000Source | 9,984,000Source |
| Operating Lease, Liability, NoncurrentUSD | 13,587,000Source | 16,767,000Source | 11,267,000Source | 14,380,000Source | 17,142,000Source | 11,937,000Source | 15,173,000Source | 17,857,000Source | 12,763,000Source | 15,955,000Source | 18,436,000Source | 20,866,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 7,862,000Source | 7,088,000Source | 8,423,000Source | 8,180,000Source | 6,702,000Source | 8,545,000Source | 7,177,000Source | 6,866,000Source | 8,531,000Source | 7,780,000Source | 5,904,000Source | 9,240,000Source |
| Long-term DebtUSD | 0Source | 27,000,000Source | 0Source | — | 27,800,000Source | 0Source | — | 28,500,000Source | 0Source | — | — | — |
| Other Liabilities, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -1,763,000Source | -2,974,000Source | 19,086,000Source | 16,960,000Source | 28,515,000Source | -17,866,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 1,639,000Source | 1,726,000Source | 6,643,000Source | 6,792,000Source | 6,539,000Source | 6,268,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,780,000Source | 2,066,000Source | 8,357,000Source | 7,819,000Source | 7,547,000Source | 9,600,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -5,676,000Source | -9,244,000Source | -1,061,000Source | 1,764,000Source | -11,653,000Source | 5,348,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,556,000Source | 201,000Source | -4,641,000Source | -3,861,000Source | -597,000Source | 3,907,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 2,171,000Source | 1,387,000Source | -758,000Source | -1,087,000Source | -3,853,000Source | 4,961,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 8,527,000Source | 1,067,000Source | -19,378,000Source | -32,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -339,000Source | 417,000Source | 42,811,000Source | 40,655,000Source | 35,855,000Source | 5,209,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -7,061,000Source | -407,000Source | -2,535,000Source | -2,497,000Source | -2,481,000Source | -1,909,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 821,000Source | 379,000Source | 2,380,000Source | 2,392,000Source | 2,324,000Source | 1,780,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 1,073,000Source | 10,018,000Source | 26,561,000Source | 3,508,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,053,000Source | -10,758,000Source | -51,197,000Source | -4,824,000Source | 5,730,000Source | -9,600,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 65,965,000Source | 82,146,000Source | 69,853,000Source | 81,528,000Source | 74,993,000Source | 83,619,000Source | 83,446,000Source | 94,367,000Source | 61,033,000Source | 21,929,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 21,000Source | 444,000Source | 1,218,000Source | 2,106,000Source | 4,560,000Source | 2,186,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 2,500,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 1,814,000Source | 2,070,000Source | 2,260,000Source | 1,939,000Source | 1,780,000Source | 2,066,000Source | 8,357,000Source | 7,819,000Source | 7,547,000Source | 9,600,000Source |
| Amortization of Intangible AssetsUSD | — | — | 900,000Source | 900,000Source | 1,100,000Source | 900,000Source | 900,000Source | 1,000,000Source | 3,700,000Source | 3,800,000Source | 3,800,000Source | 3,800,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 2,900,000Source | 3,000,000Source | 2,700,000Source | 2,500,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | -73,000Source | -5,000Source | -78,000Source | -308,000Source | -3,000Source | -20,000Source |
| General and Administrative ExpenseUSD | — | — | 21,442,000Source | 18,118,000Source | 23,360,000Source | 22,034,000Source | 23,044,000Source | 19,998,000Source | 88,705,000Source | 71,135,000Source | 62,074,000Source | 60,796,000Source |
| GoodwillUSD | — | — | 31,063,000Source | 31,063,000Source | 39,554,000Source | 31,063,000Source | 39,554,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source | 31,063,000Source |
| Income Tax Expense (Benefit)USD | — | — | 3,228,000Source | 2,078,000Source | -417,000Source | 1,307,000Source | 867,000Source | -1,097,000Source | 12,253,000Source | 6,529,000Source | -12,745,000Source | 2,393,000Source |
| InterestExpenseNonoperatingUSD | — | — | 193,000Source | 517,000Source | 19,000Source | 410,000Source | 28,000Source | 424,000Source | 1,038,000Source | 2,085,000Source | — | — |
| Investment Income, InterestUSD | — | — | 667,000Source | 969,000Source | 561,000Source | 850,000Source | 666,000Source | 895,000Source | 3,097,000Source | 3,384,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 8,209,000Source | 5,155,000Source | 7,785,000Source | 3,217,000Source | -1,763,000Source | -2,974,000Source | 19,086,000Source | 16,960,000Source | 28,515,000Source | -17,866,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -17,866,000Source |
| Nonoperating Income (Expense)USD | — | — | — | 452,000Source | — | — | — | — | — | — | -2,271,000Source | -2,715,000Source |
| Operating ExpensesUSD | — | — | 54,038,000Source | 48,006,000Source | 58,523,000Source | 54,710,000Source | 59,148,000Source | 49,888,000Source | 220,867,000Source | 194,507,000Source | 177,092,000Source | 188,734,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 34,625,000Source | 1,286,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 20,000Source | 10,000Source | 222,000Source | 24,000Source | 14,000Source | 153,000Source |
| Sales-type Lease, Selling Profit (Loss)USD | — | — | 6,007,000Source | 7,222,000Source | 6,488,000Source | 5,745,000Source | 5,907,000Source | 6,768,000Source | 26,239,000Source | 25,491,000Source | 22,353,000Source | 24,250,000Source |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 85,755,000Source | 73,093,000Source | 85,698,000Source | 78,905,000Source | 75,267,000Source | 61,268,000Source | 329,522,000Source | 292,984,000Source | 274,423,000Source | 246,785,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | 10,963,000Source | 6,781,000Source | 6,826,000Source | 4,083,000Source | -1,534,000Source | -4,542,000Source | 29,279,000Source | 22,181,000Source | 18,041,000Source | -12,758,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 11,437,000Source | 7,233,000Source | 7,368,000Source | 4,524,000Source | -896,000Source | -4,071,000Source | 31,339,000Source | 23,489,000Source | 15,770,000Source | -15,473,000Source |
| Income Tax Expense (Benefit)USD | — | — | 3,228,000Source | 2,078,000Source | -417,000Source | 1,307,000Source | 867,000Source | -1,097,000Source | 12,253,000Source | 6,529,000Source | -12,745,000Source | 2,393,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 8,209,000Source | 5,155,000Source | 7,785,000Source | 3,217,000Source | -1,763,000Source | -2,974,000Source | 19,086,000Source | 16,960,000Source | 28,515,000Source | -17,866,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.37Source | 0.21Source | 0.34Source | 0.14Source | -0.08Source | -0.13Source | 0.83Source | 0.71Source | 1.24Source | -0.89Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.36Source | 0.21Source | 0.34Source | 0.14Source | -0.08Source | -0.13Source | 0.82Source | 0.7Source | 1.23Source | -0.89Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 22,318,570Source | 23,985,364Source | 22,676,673Source | 23,092,469Source | 22,561,053Source | 23,710,643Source | 22,872,841Source | 23,883,729Source | 22,925,497Source | 20,067,969Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 22,513,140Source | 24,254,176Source | 23,058,902Source | 23,237,671Source | 22,561,053Source | 23,710,643Source | 23,295,328Source | 24,138,244Source | 23,176,169Source | 20,067,969Source |
| Interest Expense (non-operating)USD | — | — | 193,000Source | 517,000Source | 19,000Source | 410,000Source | 28,000Source | 424,000Source | 1,038,000Source | 2,085,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 900,000Source | 900,000Source | 1,100,000Source | 900,000Source | 900,000Source | 1,000,000Source | 3,700,000Source | 3,800,000Source | 3,800,000Source | 3,800,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 3,690,000Source | 5,669,000Source | 6,485,000Source | 2,475,000Source |
| General and Administrative ExpenseUSD | — | — | 21,442,000Source | 18,118,000Source | 23,360,000Source | 22,034,000Source | 23,044,000Source | 19,998,000Source | 88,705,000Source | 71,135,000Source | 62,074,000Source | 60,796,000Source |
| Gross ProfitUSD | — | — | 65,001,000Source | 54,787,000Source | 65,349,000Source | 58,793,000Source | 57,614,000Source | 45,346,000Source | 250,146,000Source | 216,688,000Source | 195,133,000Source | 175,976,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | 0.37Source | 0.21Source | 0.34Source | 0.14Source | -0.08Source | -0.13Source | 0.83Source | 0.71Source | 1.24Source | -0.89Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | 0.36Source | 0.21Source | 0.34Source | 0.14Source | -0.08Source | -0.13Source | 0.82Source | 0.7Source | 1.23Source | -0.89Source |
| Investment Income, InterestUSD | — | — | 667,000Source | 969,000Source | 561,000Source | 850,000Source | 666,000Source | 895,000Source | 3,097,000Source | 3,384,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -17,866,000Source |
| Nonoperating Income (Expense)USD | — | — | — | 452,000Source | — | — | — | — | — | — | -2,271,000Source | -2,715,000Source |
| Operating ExpensesUSD | — | — | 54,038,000Source | 48,006,000Source | 58,523,000Source | 54,710,000Source | 59,148,000Source | 49,888,000Source | 220,867,000Source | 194,507,000Source | 177,092,000Source | 188,734,000Source |
| Research and Development ExpenseUSD | — | — | 2,191,000Source | 2,417,000Source | 2,501,000Source | 2,018,000Source | 2,776,000Source | 1,741,000Source | 8,481,000Source | 8,832,000Source | 7,823,000Source | 7,088,000Source |
| Sales-type Lease, Selling Profit (Loss)USD | — | — | 6,007,000Source | 7,222,000Source | 6,488,000Source | 5,745,000Source | 5,907,000Source | 6,768,000Source | 26,239,000Source | 25,491,000Source | 22,353,000Source | 24,250,000Source |
| Selling and Marketing ExpenseUSD | — | — | 29,809,000Source | 26,838,000Source | 32,012,000Source | 30,039,000Source | 32,732,000Source | 27,516,000Source | 121,237,000Source | 112,009,000Source | 107,119,000Source | 106,418,000Source |
Filing attachments
tcmd-ex99d1.htm · 8-K · 2026-11-02
Exhibit 99.1 Tactile Systems Technology, Inc. Reports Third Quarter 2026 Financial Results MINNEAPOLIS, MN, November 2, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 7% year-over-year to $91.9 million;…
Read attachment ↗tcmd-20260810xex99d1.htm · 8-K · 2026-08-10
EX-99.1 2 tcmd-20260810xex99d1.htm EX-99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results MINNEAPOLIS, MN, August 10th, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Summary and Recent Business Highlights: Total revenue…
Read attachment ↗tm2620304d1_ex99-1.htm · 8-K · 2026-07-13
EX-99.1 2 tm2620304d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with …
Read attachment ↗tcmd-20260504xex99d1.htm · 8-K · 2026-05-04
EX-99.1 2 tcmd-20260504xex99d1.htm EX-99.1 Exhibit 99.1 Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results MINNEAPOLIS, MN, May 4th, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary and Recent Business Highlights: Total revenue incre…
Read attachment ↗tm268267d1_ex99-1.htm · 8-K · 2026-03-09
EX-99.1 2 tm268267d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson MINNEAPOLIS, MN, March 9, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company’s Board of Directors (“Board”) and as a member of the Compliance & Reimbursement and Nom…
Read attachment ↗tcmd-20260217xex99d1.htm · 8-K · 2026-02-17
Exhibit 99.1 Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results MINNEAPOLIS, MN, February 17, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Summary: Total revenue increased 21% year-over-year to $103.6 millio…
Read attachment ↗